We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FTC Approves Novartis' Acquisition of Chiron
FTC Approves Novartis' Acquisition of Chiron
December 9, 2005
Novartis’ proposed $5.1 billion acquisition of vaccine maker Chiron cleared an important hurdle this week, receiving regulatory approval from the FTC.